Nexentis: MitoCareX Bio Expands Computational Biology Capabilities to Advance Disease-Pathway Analysis
Go back to Nexentis: MitoCareX Bio Expands Computational Biology Capabilities to Advance Disease-Pathway Analysis| (NASDAQ: NXTS) | Delayed: 0.70 -0.06 (7.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.76 | 52 Week High | $ | |||
| Open | $0.71 | 52 Week Low | $ | |||
| Day High | $0.75 | P/E | N/A | |||
| Day Low | $0.64 | EPS | $ | |||
| Volume | 119,281 | |||||



